BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
11.61
+1.11 (10.57%)
At close: Dec 5, 2025, 4:00 PM EST
11.69
+0.08 (0.69%)
After-hours: Dec 5, 2025, 7:59 PM EST
BioAge Labs Analyst Ratings
Total Analysts
4
Consensus Rating
Hold
Price Target
$9.00
Upside
-22.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | +29.20% | Oct 29, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $5 → $10 | Hold → Strong Buy | Upgrades | $5 → $10 | -13.87% | Oct 22, 2025 |
| Citigroup | Citigroup | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | -56.93% | Mar 24, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Initiates $5 | Sell | Initiates | $5 | -56.93% | Mar 7, 2025 |
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $45 → $7 | Strong Buy → Hold | Downgrades | $45 → $7 | -39.71% | Dec 9, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $42 → $7 | Strong Buy → Hold | Downgrades | $42 → $7 | -39.71% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +287.60% | Oct 21, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +244.53% | Oct 21, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +261.76% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $1.75 | Strong Buy | Maintains | $12 → $1.75 | -84.93% | Mar 29, 2018 |
| Cowen & Co. | Cowen & Co. | Hold Initiates $2.5 | Hold | Initiates | $2.5 | -78.47% | Apr 12, 2017 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +55.04% | Jan 5, 2016 |